Eagle to price its IPO of 3,333,333 shares between $14.00 and $16.00

Piper Jaffray and William Blair will be the joint bookrunning managers

By Devika Patel

Knoxville, Tenn., Feb. 4 - Eagle Pharmaceuticals, Inc. will sell 3,333,333 common shares in its initial public offering with a 30-day greenshoe of 500,000 additional shares, according to a Form S-1/A filed Tuesday with the Securities and Exchange Commission. The deal was announced Dec. 20.

The shares will be sold at a price expected to fall between $14.00 and $16.00 per share.

Existing shareholders have indicated that they plan to buy $10 million of the stock.

Piper Jaffray and William Blair are the joint bookrunners. Cantor Fitzgerald & Co. is the co-manager.

Proceeds will be used for research and development, sales and marketing, working capital and general corporate purposes.

The specialty pharmaceutical company is based in Woodcliff Lake, N.J. It expects to list its common stock on an exchange under the symbol "EGRX."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.